Next Article in Journal
Trans-Ferulic Acid-4-β-Glucoside Alleviates Cold-Induced Oxidative Stress and Promotes Cold Tolerance
Next Article in Special Issue
Modeling Endometrial Cancer: Past, Present, and Future
Previous Article in Journal
Pin1 Modulation in Physiological Status and Neurodegeneration. Any Contribution to the Pathogenesis of Type 3 Diabetes?
Previous Article in Special Issue
Liquid Biopsy in Endometrial Cancer: New Opportunities for Personalized Oncology
Article Menu
Issue 8 (August) cover image

Export Article

Open AccessReview
Int. J. Mol. Sci. 2018, 19(8), 2320;

Vitamin D and Endometrium: A Systematic Review of a Neglected Area of Research

Reproductive Sciences Laboratory, Division of Genetics and Cell Biology, IRCCS San Raffaele Scientific Institute, 20132 Milano, Italy
Obstetrics and Gynaecology Department, IRCCS San Raffaele Scientific Institute, 20132 Milano, Italy
Author to whom correspondence should be addressed.
Received: 6 July 2018 / Revised: 2 August 2018 / Accepted: 4 August 2018 / Published: 8 August 2018
(This article belongs to the Special Issue Molecular Research of Endometrial Pathophysiology)
Full-Text   |   PDF [565 KB, uploaded 8 August 2018]   |  


Growing evidence supports a role of vitamin D (VD) in reproductive health. Vitamin D receptor (VDR) is expressed in the ovary, endometrium, and myometrium. The biological actions of VD in fertility and reproductive tissues have been investigated but mainly using animal models. Conversely, the molecular data addressing the mechanisms underlying VD action in the physiologic endometrium and in endometrial pathologies are still scant. Levels of VDR expression according to the menstrual cycle are yet to be definitively clarified, possibly being lower in the proliferative compared to the secretory phase and in mid-secretory compared to early secretory phase. Endometrial tissue also expresses the enzymes involved in the metabolism of VD. The potential anti-proliferative and anti-inflammatory effects of VD for the treatment of endometriosis have been investigated in recent years. Treatment of ectopic endometrial cells with 1,25(OH)2D3 could significantly reduce cytokine-mediated inflammatory responses. An alteration of VD metabolism in terms of increased 24-hydroxylase mRNA and protein expression has been demonstrated in endometrial cancer, albeit not consistently. The effect of the active form of the vitamin as an anti-proliferative, pro-apoptotic, anti-inflammatory, and differentiation-inducing agent has been demonstrated in various endometrial cancer cell lines. View Full-Text
Keywords: Vitamin D; endometrium; endometrial cancer Vitamin D; endometrium; endometrial cancer

Figure 1

This is an open access article distributed under the Creative Commons Attribution License which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited (CC BY 4.0).

Share & Cite This Article

MDPI and ACS Style

Cermisoni, G.C.; Alteri, A.; Corti, L.; Rabellotti, E.; Papaleo, E.; Viganò, P.; Sanchez, A.M. Vitamin D and Endometrium: A Systematic Review of a Neglected Area of Research. Int. J. Mol. Sci. 2018, 19, 2320.

Show more citation formats Show less citations formats

Note that from the first issue of 2016, MDPI journals use article numbers instead of page numbers. See further details here.

Related Articles

Article Metrics

Article Access Statistics



[Return to top]
Int. J. Mol. Sci. EISSN 1422-0067 Published by MDPI AG, Basel, Switzerland RSS E-Mail Table of Contents Alert
Back to Top